Drug Database
Back to search

Belgium· BE-AMP-SAM051073-00

Locasalen

A flumetasone product containing flumetasone pivalate, registered in Belgium by Amdipharm. The same ATC class is registered in 4 of our 19 countries.

ATC D07XB01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedLocasalenATCD07XB01REGISTER NO.BE-AMP-SAM051073-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about flumetasone pivalateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Flumetasone is registered in 4 of 19 countries.

Countries holding a registration under ATC D07XB01 (flumetasone), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 3 of them publish a price we can compare per daily dose
Search flumetasone products by name

Flumetasone · ATC D07XB01

4 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Flumetasone Pivalate
Manufacturer
Amdipharm
Country
Belgium (BE)
ATC code
D07XB01
ATC class
Flumetasone
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0053868

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Flumetasone in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All flumetasone products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Cerson, Cerson Fettcreme
  • Netherlands · Locacorten

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5972eeb4-ebc4-41a3-946f-4c276e2e27dd
GET /v1/drugs/5972eeb4-ebc4-41a3-946f-4c276e2e27dd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Ointment",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Locasalen",
  "name_fr": "Locasalen",
  "name_nl": "Locasalen",
  "amp_code": "SAM051073-00",
  "strengths": [
    "0.2000",
    "0.2000",
    "30.0000",
    "30.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Flumetasone Pivalate",
    "Salicylic Acid"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Flumetasone",
  "authorisation_numbers": [
    "BE051073"
  ]
}
API referenceMCP serverPlans

See everything about flumetasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console